Johnson & Johnson has a deep history of investing in Israel, including acquiring ‘Israeli’ med-tech company Biosense in 1994 for $400m, opening a med-tech incubator in Israel in 2014 and more recently in 2024, acquiring the Israeli med-tech company V-Wave for up to $1.7bn, marking the biggest acquisition in Israel’s history.
Johnson & Johnson’s top shareholders are also the deeply complicit Vanguard, BlackRock and State Street Corporation.